Prof. Mary-Claire King - a member of the Israel Precision Medicine Partnership Scientific Advisory Committee - is the scientist who discovered the BRCA1 gene, responsible for hereditary predisposition to breast and ovarian cancers. In this interview with the Israeli newspaper The Marker, she discusses how the Partnership has propelled scientific research in Israel to a level on par with that of the U.S. For the full article, please click the file below. Translated from the Hebrew original.